Cantourage Group SEHAM:HIGH -5.83%20 Return-on-Tangible-Equity is 0.16% as of Jun. 2025. GuruFocus rates HAM:HIGH with a GF Score™ of 20/100. The stock has 4 warning signs investors should review. Among 898 Drug Manufacturers companies, Cantourage Group SE ranks worse than 70.94% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Cantourage Group SE's annualized net income for the quarter that ended in Jun. 2025 was €0.07 Mil. Cantourage Group SE's average shareholder tangible equity for the quarter that ended in Jun. 2025 was €44.42 Mil. Therefore, Cantourage Group SE's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2025 was 0.16%.
The historical rank and industry rank for Cantourage Group SE's Return-on-Tangible-Equity or its related term are showing as below:
HAM:HIGH'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -48.19 Med: -18.6 Max: 0.08
Current: 0.08
During the past 5 years, Cantourage Group SE's highest Return-on-Tangible-Equity was 0.08%. The lowest was -48.19%. And the median was -18.60%.
HAM:HIGH's Return-on-Tangible-Equity is ranked worse than 70.94% of 898
companies
in the Drug Manufacturers industry
Industry Median: 7.88
vs HAM:HIGH: 0.08
Cantourage Group SE (HAM:HIGH) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Cantourage Group SE Return-on-Tangible-Equity Related Terms
Cantourage Group SE Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Cantourage Group SE's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cantourage Group SE Return-on-Tangible-Equity Chart
HAM:HIGH vs ZTS, UTHR, VTRS: Return-on-Tangible-Equity Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cantourage Group SE Return-on-Tangible-Equity vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Cantourage Group SE's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Jun. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.16% mean?
Cantourage Group SE (HAM:HIGH) has a Return-on-Tangible-Equity of 0.16% as of Jun. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Cantourage Group SE and its competitors. According to the industry distribution chart, Cantourage Group SE ranks #637 out of 898 companies in the Drug Manufacturers industry, placing it in the top 70.9%.
Is Cantourage Group SE's Return-on-Tangible-Equity too high?
Cantourage Group SE's current Return-on-Tangible-Equity is 0.16%. The Drug Manufacturers industry median Return-on-Tangible-Equity is 7.88. Cantourage Group SE's value of 0.16% is 98% below this industry median. Based on the distribution chart, Cantourage Group SE ranks #637 out of 898 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Cantourage Group SE has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Cantourage Group SE's Return-on-Tangible-Equity compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cantourage Group SE ranks #637 out of 898 companies for Return-on-Tangible-Equity. This places Cantourage Group SE in the lower half of its industry. The industry median Return-on-Tangible-Equity is 7.88. Cantourage Group SE's value of 0.16% is 98% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Drug Manufacturers company?
The median Return-on-Tangible-Equity among Drug Manufacturers companies is 7.88, based on 898 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cantourage Group SE's current Return-on-Tangible-Equity of 0.16% is 98% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Cantourage Group SE and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Equity is 7.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cantourage Group SE's current Return-on-Tangible-Equity is 0.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantourage Group SE stock overvalued right now?
Cantourage Group SE (HAM:HIGH) has a current Return-on-Tangible-Equity of 0.16%. The current Return-on-Tangible-Equity is 0.16% and 98% below the Drug Manufacturers industry median of 7.88. Cantourage Group SE's overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Cantourage Group SE (HAM:HIGH), the current Return-on-Tangible-Equity is 0.16% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cantourage Group SE is engaged in the manufacture and wholesale of medicinal preparations based on cannabis and the trade and distribution of other legally permissible cannabis products, medical devices, pharmaceuticals, and accessories. The group offers cannabis flowers, dronabinol, CBD, and extracts of various strains.
20GF Score
Get the complete analysis for HAM:HIGH
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:HIGH has been successfully added to your 
